Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +3.73% rose 3.78% to $135.80 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.75% rising 2.68% to 11,740.65 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.42% rising 1.61% to 32,637.19. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $361.69 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.08% fell 0.91% to $150.57, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.48% rose 0.02% to $253.05, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.67% fell 0.16% to $66.70. Trading volume (5.1 M) remained 1.5 million below its 50-day average volume of 6.6 M.